Xstrahl Medical Solutions

Specialist clinical solutions for medical practitioners
and their patients across the world

Treatment
Solutions
Basal Cell Carcinoma
Squamous Cell Carcinoma
Keloid
Dermatological Conditions
Mycosis
Fungoides
Palliative Care
Benign Conditions

Treatment Solutions

Our Xstrahl therapy range comprises 4 systems that span low energy units for superficial treatments of clinical conditions through to higher energy units for orthovoltage treatments.

Xstrahl 100	Low energy option, superficial and Grenz Ray therapy system.
Xstrahl 150	Superficial therapy system, higher energy range and larger depth dose than the Xstrahl 100.
Xstrahl 200	Superficial and orthovoltage system, treats the same superficial conditions as the Xstrahl 100 and 200 and provides palliative treatments.
Xstrahl 300	The most powerful system in the Xstrahl range, this system is ideally suited for orthovoltage techniques.

Basal Cell Carcinoma

Basal Cell Carcinoma is the most common form of skin cancer. The tumours typically occur in exposed areas; mostly the face and head. The cancers rarely metastasize and therefore fatalities are exceptionally uncommon. Multiple primary tumours often occur and may be large in size, causing discomfort and disfigurement.

Xstrahl 100 Xstrahl 150 Xstrahl 200 Xstrahl 300

Squamous Cell Carcinoma

The incidence of Squamous Cell Carcinomas is lower than that of Basal Cell Carcinomas, but it is the more aggressive variety, with a higher mortality rate. Like Basal Cell Carcinomas, the cause is often associated with sun exposure, although in the case of Squamous Cell Carcinomas, cancer is more likely to metastasize.

Xstrahl 100 Xstrahl 150 Xstrahl 200 Xstrahl 300

Keloid

Keloid scarring often forms at the site of skin injuries, and typically is shiny and dark pink or brown in appearance. Radiotherapy is an effective form of treatment; particularly if executed soon after formation of the scar.

Xstrahl 100 Xstrahl 150 Xstrahl 200 Xstrahl 300

Dermatological Conditions

Benign skin conditions that include inflammatory disorders, degenerative disorders and hypertrophic disorders.

Xstrahl 100 Xstrahl 150

Mycosis Fungoides

Mycosis Fungoides is a class of cutaneous T Cell Lymphoma affecting the skin. Small, localised, superficial lesions can be successfully treated with low energy X-ray therapy to provide effective palliation of symptoms.

Xstrahl 100 Xstrahl 150

Palliative Care

Xstrahl systems can be used as a source of palliative care, to improve the quality of life of patients. X-ray therapy is used to treat painful boney metastases.

Xstrahl 200 Xstrahl 300

Benign Conditions

Radiotherapy is sometimes used to treat benign conditions. Superficial X-ray therapy can provide symptomatic control in such benign conditions as Dupytrens Contracture and for many benign tumours of skin and other soft tissues.

Xstrahl 100 Xstrahl 150 Xstrahl 200 Xstrahl 300

Xstrahl 150

The Xstrahl 150 X-Ray system is a higher energy superficial treatment unit than the Xstrahl 100 making it ideal for treating superficial skin lesions including squamous cell carcinoma as well as medium sized
benign plaques.

Designed for permanent installation within the radiotherapy suite, the Xstrahl 150 system can be mounted on a floor or ceiling stand to suit the user and room set-up. The intuitive machine controls have been ergonomically designed to provide the operator with smooth, controlled movements at all times allowing the radiation therapist to easily position the unit ensuring patient comfort wherever the treatment site.

Clinical Conditions

Basal cell carcinoma
Squamous cell carcinoma
Keloid scars
Dermatological conditions including psoriasis
Mycosis fungoides and other deeper benign plaques

Technical Specifications

Tube Voltage 10 - 150 kV
Tube Current 0 - 30 mA
Maximum HVL 8 mm Al
Maximum Power Output 3 kW

Output Data

Typical Dose Rate 300 cGy/min
Field size 1.5 cm�15 cm diameter


kV	120	140
HVL (mm)	4 Al	8 Al
mA	4.5	6.4
FSD	15	15
Typical Dose Rate 100�300 cGy/min	300	300
Maximum Dose Rate cGy/min	1563	275

The Xstrahl control system provides a simple, intuitive interface for both physicists and radiation therapists, to assist with delivering and reviewing patient and treatment data.

All Xstrahl products have received CE marking approval for sale in Europe, clearance by FDA for sale in the U.S.A., are licensed for sale in Canada and are designed and manufactured in accordance with an ISO13485:2003 certified quality management system.